ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 283 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $660,164 | +22.0% | 21,574 | +7.1% | 0.13% | +9.5% |
| Q3 2023 | $541,027 | -12.1% | 20,135 | +16.7% | 0.12% | -5.7% |
| Q2 2023 | $615,313 | +54.7% | 17,255 | +10.2% | 0.12% | +7.0% |
| Q1 2023 | $397,815 | -42.7% | 15,662 | -8.5% | 0.12% | -82.9% |
| Q4 2022 | $694,468 | +20.2% | 17,122 | -2.1% | 0.67% | +26.9% |
| Q3 2022 | $578,000 | -15.4% | 17,489 | -9.8% | 0.53% | +2.1% |
| Q2 2022 | $683,000 | -27.9% | 19,399 | -5.8% | 0.52% | +16.6% |
| Q1 2022 | $947,000 | -43.7% | 20,602 | -18.8% | 0.45% | -27.1% |
| Q4 2021 | $1,681,000 | – | 25,358 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |